NASDAQ:IOVA - Nasdaq - US4622601007 - Common Stock - Currency: USD
Taking everything into account, IOVA scores 3 out of 10 in our fundamental rating. IOVA was compared to 562 industry peers in the Biotechnology industry. The financial health of IOVA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, IOVA is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -40.88% | ||
ROE | -52.39% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 24.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -2.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.74 | ||
Quick Ratio | 3.31 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:IOVA (5/16/2025, 9:40:10 AM)
1.655
-0.1 (-5.97%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 3.37 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.78 | ||
P/tB | 1.29 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -40.88% | ||
ROE | -52.39% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 24.43% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 33.37% | ||
Cap/Sales | 6.75% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 3.74 | ||
Quick Ratio | 3.31 | ||
Altman-Z | -2.69 |